Aidi Injection, Compound Kushen Injection, or Kanglaite Injection: Which Is the Best Partner with Systemic Chemotherapy for Patients with HCC? A Network Meta-Analysis.

Dou, Dou; Zhang, Ze-Yu; Wu, Zhi-Yuan; Qiu, Xu-Dong; Zhong, Xiang-Gen

Dou, Dou; Zhang, Ze-Yu; Wu, Zhi-Yuan; Qiu, Xu-Dong; Zhong, Xiang-Gen.

Afiliación

Dou D; School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Zhang ZY; China-Japan Friendship Hospital, Beijing, China.
Wu ZY; School of Public Health, Capital Medical University, Beijing, China.
Qiu XD; School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Zhong XG; School of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

Evid Based Complement Alternat Med ; 2020: 5497041, 2020.

Article en En | MEDLINE | ID: mdl-32904600

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Evid Based Complement Alternat Med Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google